CorMedix Inc. Quarterly General and Administrative Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
CorMedix Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2010 to Q3 2024.
  • CorMedix Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $6.58M, a 75.7% increase year-over-year.
  • CorMedix Inc. annual General and Administrative Expense for 2018 was $8.07M, a 6.68% decline from 2017.
  • CorMedix Inc. annual General and Administrative Expense for 2017 was $8.65M, a 2.6% decline from 2016.
  • CorMedix Inc. annual General and Administrative Expense for 2016 was $8.88M, a 13.5% decline from 2015.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.58M +$2.84M +75.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $7.56M +$3.81M +101% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q3 2023 $3.74M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $3.75M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q4 2016 $8.88K $2.43K +$166 +7.32% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-16
Q3 2016 $8.72K $2.32K -$631 -21.4% Jul 1, 2016 Sep 30, 2016 10-K 2017-03-16
Q2 2016 $9.35K $1.97K -$387 -16.4% Apr 1, 2016 Jun 30, 2016 10-K 2017-03-16
Q1 2016 $9.73K $2.16K -$530 -19.7% Jan 1, 2016 Mar 31, 2016 10-K 2017-03-16
Q4 2015 $10.3K $2.27K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 $2.95K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 $2.36K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 $2.69K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2013 $3.49M $1.52M +$1.33M +671% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $2.16M $505K -$242K -32.4% Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-03-04
Q2 2013 $2.4M $909K +$532K +141% Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-03-04
Q1 2013 $1.87M $552K +$15.5K +2.89% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-03-04
Q4 2012 $1.86M $198K -$342K -63.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $2.2M $747K -$130K -14.9% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-03-04
Q2 2012 $2.33M $377K -$521K -58.1% Apr 1, 2012 Jun 30, 2012 10-Q/A 2014-03-04
Q1 2012 $2.85M $536K -$298K -35.7% Jan 1, 2012 Mar 31, 2012 10-Q/A 2014-03-04
Q4 2011 $3.15M $539K Oct 1, 2011 Dec 31, 2011 10-K/A 2014-03-04
Q3 2011 $877K +$235K +36.6% Jul 1, 2011 Sep 30, 2011 10-Q/A 2013-03-27
Q2 2011 $898K +$280K +45.4% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-06
Q1 2011 $834K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $642K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $618K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.